GlassScriptPhysician profile
John P Sugrue
NPI 1245211085
$17,151.25
in general payments reported to CMS, 2019-2025
37 companies · $4,339 in 2025
The $4,339 reported for 2025 was more than what 95% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,419 · 2020: $1,979 · 2021: $905 · 2022: $1,867 · 2023: $1,618 · 2024: $2,024 · 2025: $4,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,269 · Travel and Lodging: $1,604 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,268.50 |
| Travel and Lodging | $1,603.59 |
| Education | $109.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $4,050.63 | 2019-2025 | |
| Inspire Medical Systems, INC. | $2,611.85 | 2020-2025 | Inspire |
| Aerin Medical INC. | $2,532.66 | 2019-2025 | |
| Stryker Corporation | $1,732.86 | 2019-2025 | Clarifix, Scopis Ent, Xpress Loprofile |
| Intersect Ent, INC. | $1,598.92 | 2019-2022 | |
| Glaxosmithkline, LLC. | $974.75 | 2019-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $908.07 | 2019-2025 | Dupixent |
| Genzyme Corporation | $744.62 | 2019-2025 | |
| Medtronic, INC. | $391.19 | 2023-2024 | Propel, Sinuva |
| Kaleo, INC. | $125.49 | 2019-2024 | Auvi-Q |
| Integra Lifesciences Corporation | $123.67 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Pfizer INC. | $115.50 | 2022-2025 | |
| Livanova USA, INC. | $108.31 | 2021 | |
| Acclarent, INC | $97.36 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $96.09 | 2019-2023 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $88.65 | 2024 | Ryaltris |
| Harmony Biosciences LLC | $85.32 | 2021-2024 | |
| Spirair, INC. | $76.16 | 2025 | |
| Zoll Respicardia, INC. | $68.91 | 2024 | Remede System |
| Novartis Pharmaceuticals Corporation | $62.25 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.70 | 2020-2024 | Cuvitru |
| Jazz Pharmaceuticals INC. | $53.32 | 2020-2021 | |
| Paratek Pharmaceuticals, INC. | $49.92 | 2025 | Xhance |
| Axsome Therapeutics, INC. | $49.78 | 2024-2025 | Sunosi |
| Genentech USA, INC. | $49.10 | 2024-2025 | Xolair |
| Amgen INC. | $40.70 | 2022-2025 | Tezspire |
| Alk-Abello, INC | $38.11 | 2019-2021 | |
| Csl Behring | $34.84 | 2024-2025 | Hizentra |
| Astrazeneca Pharmaceuticals LP | $30.97 | 2023-2025 | Tezspire |
| Grifols USA, LLC | $25.32 | 2025 | Xembify |
| Incyte Corporation | $22.90 | 2025 | Opzelura |
| Arbor Pharmaceuticals, INC. | $22.31 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $19.41 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $18.92 | 2025 | Neffy |
| 3b Medical, INC. | $14.83 | 2025 | Luna |
| Shire North American Group INC | $14.43 | 2019 | |
| Cook Medical LLC | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sugrue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.